ChemCon News

You are here: News & Events

Events

To top

News

ChemCon invests in expansion of its quality control department - new ICP-MS unit goes into operation

Determination of elemental concentrations in pharmaceutical products can now be routinely performed at ChemCon via ICP–MS in conformation with USP and .Read more...

ChemCon GmbH successfully passes its fourth FDA inspection

ChemCon has successfully passed another inspection by the U.S. Food and Drug Administration (FDA). ChemCon, based in Freiburg, Germany, is a specialist for contract research and offers custom synthesis of active pharmaceutical ingredients (APIs) and...Read more...

ChemCon receives a spontaneous visit by the newly elected member of the Bundestag Matern von Marshall

On Nov. 21st, 2013 ChemCon CEO Dr. Raphael Vogler was delighted and surprised by the spontaneous visit of the newly elected parliamentarian Matern von Marshall. The two engaged in an informal conversation about the economic prospects of biotech and...Read more...

ChemCon receives approval to manufacture semi-solid pharmaceuticals for human use

Following a successful inspection by the German health authorities in July 2013 ChemCon received the approval required to manufacture semi-solid pharmaceuticals (gels and creams for topical therapy) for human use. This was an important step for the...Read more...

ChemCon participates in the event "Ideen treffen Gründer"

ChemCon started on the road to success in 1997 when the two founders, Dr. Raphael Vogel and Dr. Peter Gockel, continued a successful partnership that began in the research laboratories of the University of Freiburg. The two young and...Read more...

To top